People who see images of their badly clogged arteries are more likely to lose weight and take anti-cholesterol drugs than people who don’t see severe disease on a computerized scan, researchers said Saturday. Two studies presented at the American College of Cardiology annual meeting in Chicago showed that having a look at the real-time effect of one’s own lifestyle habits was a major motivator for change. The findings are important because convincing people to regularly take cholesterol-lowering drugs is a key hurdle in medicine and many patients are reluctant to make the changes needed until it is too late. “Seeing a coronary artery calcium scan gives patients a visual picture of how severe their disease is, and this picture seems to have a really big impact,” said Nove Kalia, one of the lead investigators for both studies. The most striking results were seen among patients with the most severe disease, or whose inner arteries had grown clogged due to such factors as overeating, smoking, high blood pressure or diabetes. Patients undergoing coronary artery calcium (CAC) scoring with cardiac computed tomography, or a CT scan that shows images of the heart, were shown images of their arteries. Those with the worst arteries, or whose CAC topped 400 or more, were 2.5 times more likely to take statins as directed and more than three times more likely to have lost weight, according to a follow up questionnaire, compared to those whose scans showed little evidence of disease. The statin study followed 2,100 patients and the weight loss study tracked a total of 518. Neither study was able to show whether the scans caused enough of a behavioral change to ward off future heart attacks or stroke. “With increasing use of noninvasive imaging, it seems we already have a powerful tool in helping to motivate patients,” said Kalia in a statement. “I think we may find this can also help improve outcomes.”
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor